Abelacimab FXII factor XIIa prevention stroke
Generic: abelacimab
Manufacturer: Novartis · Program:
Apply for AssistanceEligibility Criteria
Insurance Requirement
See program details
Residency
US residency required
Program Information
Processing Time
2–8 weeks
Delivery Method
Varies by program
Application Method
Online
Indicated For
stroke prevention, systemic embolism prevention in atrial fibrillation
About This Medication
# Novartis Patient Assistance Foundation (NPAF) Patient Guide: How to Get Novartis Medications at Low or No Cost The **Novartis Patient Assistance Foundation (NPAF)** provides **free Novartis medications** like abelacimab to eligible U.S. patients who are uninsured, have limited insurance, and meet income guidelines. This guide explains eligibility, the application process, and next steps in simple terms.[1][2][7] ## About Abelacimab and Why Assistance Matters Abelacimab is a Novartis prescription medication used to treat specific conditions (consult your doctor for details on your case). Like many specialty drugs, it can be expensive without insurance—often thousands of dollars per dose. NPAF helps by covering the full cost for qualifying patients, ensuring you get the treatment you need without financial strain.[1][2][7] Novartis runs NPAF as a nonprofit to support patients facing high drug costs. It's not a copay card but a full patient assistance program (PAP) for those who can't afford their meds. Always check www.PAP.Novartis.com for the latest list of covered drugs, as availability can change.[2][7] ## Who Qualifies for NPAF? To join NPAF, you must meet **all** these criteria: - Live in the **United States or a U.S. territory**.[1][2][7] - Have **limited or no prescription insurance coverage** (uninsured or government insurance like Medicare Part A only; no full prescription coverage).[1][2][4] - Meet **income guidelines** based on Federal Poverty Level (FPL), which vary by household size and drug.[2][7] - Have a **valid prescription** from a licensed U.S. healthcare provider for outpatient treatment.[2][3] - Not be enrolled in alternative funding programs that restrict PAP use.[1] NPAF does **not** cover patients with active private prescription insurance or certain government plans with drug coverage. If insured, you may need prior authorization (PA) denial or appeal docs.[1][2] ## Income Eligibility Breakdown Income limits are set at a percentage of the **Federal Poverty Level (FPL)** and adjust yearly. Exact thresholds depend on the medication—visit www.PAP.Novartis.com or call 1-800-277-2254 for your drug's specifics, as they're not fixed across all products.[2][7] Here's a general example table based on typical PAP structures (confirm current FPL% for abelacimab): | Household Size | Annual Income Limit (e.g., 400% FPL)* | |----------------|---------------------------------------| | 1 (Individual) | Up to $60,000 | | 2 (Couple) | Up to $81,000 | | 3 | Up to $102,000 | | 4 | Up to $123,000 | *Add ~$21,000 per additional family member. These are illustrative; actual limits are drug-specific and FPL-based. Provide proof like tax returns (first 2 pages of 1040), W-2s, pay stubs, or 1099s.[4][7] Household size matches your tax return.[1] ## Insurance Requirements - **Uninsured or limited coverage only**: No private prescription insurance. Government insurance (e.g., Medicare without Part D) may qualify.[1][2][4] - **If insured**: Submit **front/back copies of all insurance cards** (primary, secondary, Rx). Include **PA denial or appeal outcomes** if required by your plan.[1][2][3] - NPAF won't assist if insurance ties coverage to PAP enrollment.[1] Medicare patients: Eligible if no Part D or equivalent Rx coverage; confirm via PAP site.[2] ## Step-by-Step Application Process 1. **Check Eligibility**: Go to www.PAP.Novartis.com. Enter your drug (abelacimab) and income/household details.[2][7] 2. **Download Form**: Get the latest NPAF application (English/Spanish available).[1][5] 3. **Fill Patient Section**: Provide name, address, SSN or Green Card ID, DOB, household size, income proof, insurance details. Sign for medical info release.[1][2][3] 4. **Doctor's Role**: Your prescriber completes their section, signs, and provides a **separate valid prescription** (E-scribe or fax original if state-required, e.g., NY/DE). Include PA docs if needed.[1][2][3] 5. **Gather Documents**: - Income proof (tax return pages 1-2, W-2, pay stubs, 1099).[4][7] - Insurance cards (front/back).[1] - PA/appeal denials.[1][2] 6. **Submit**: **Fax** complete form to 1-855-817-2711 or **mail** to NPAF, PO Box 2529, Columbus, OH 43216. Incomplete apps delay or deny.[1][5][7] **Tip**: Use checklists in forms to avoid errors.[3] ## Timeline and Delivery - **Processing**: About **4 weeks** after full submission. You'll get a written decision letter.[7][8] - **If Approved**: Meds shipped free to your doctor's office or home (confirm with NPAF). Annual re-review required.[8] - **Refills**: Reauthorization needed yearly; resubmit updated income/docs.[8] Call 1-800-277-2254 (Mon-Fri, 9am-6pm ET) for status.[3][7][8] ## Alternatives if Denied or Ineligible - **Appeal**: Contact NPAF if docs were incomplete.[1] - **Other Novartis Programs**: Check copay cards or Patient Support at drug-specific sites (e.g., for other Novartis meds).[6][9] - **General Resources**: NeedyMeds, RxAssist, or PAN Foundation. State programs or 340B clinics. - **Biosimilars**: None listed for abelacimab currently. - **Generic Options**: Discuss with doctor; NPAF is brand-specific. ## Disclaimer This guide is for informational purposes based on publicly available NPAF details as of latest forms. Eligibility, income limits, and processes can change—**always verify at www.PAP.Novartis.com or call 1-800-277-2254**. NPAF isn't guaranteed; decisions are final. Consult your healthcare provider before starting/stopping meds. Not medical/financial advice.
Program information last verified: March 30, 2026
Ready to apply for Abelacimab FXII factor XIIa prevention stroke assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.